New Developments in Gut Health & its Relationship to Systemic Illness - Nov. 16 - 18, 2012 - Planet Hollywood Resort & Casino - Las Vegas
bowel disease (IBD) is one of the five most prevalent gastrointestinal
disease burdens in the United States, with an overall health care cost
of more than $1.7 billion. This chronic condition is without a medical
cure and commonly requires a lifetime of care. Each year in the United
States, IBD accounts for more than $700,000 physician visits, 100,000
hospitalization, and disability in 119,000 patients. Over the long term,
up to 75% of patients with Crohn's disease and 25% of those with
ulcerative colitis will require surgery.
to a recent article in the gastroenterology literature: Complementary
and alternative medicine (CAM) is commonly used by the general public
and by those suffering from chronic diseases including individuals with
Crohn's disease (CD) and ulcerative colitis. This increase in patients'
use of CAM has spurred interest in CAM among gastroenterologists and
other physician's general knowledge of CAM efficacy in IBD is lacking
and most physicians are unprepared to advise their patients about CAM or
understand the application and appropriate use of CAM therapies in IBD
or know the effect these therapies will have on conventional IBD
therapies. According to multiple surveys published in the
gastroenterology literature, patients using CAM report benefits that
extend beyond simply improved disease control. Using CAM allows patients
to exert a greater degree of control over their disease and its
management than they are afforded by conventional medicine.
intestinal bacterial overgrowth (SIBO) is implicated in irritable bowel
syndrome and is difficult to both diagnose and treat. This treatment
challenge arises mainly because a specific algorithm for the treatment
of irritable bowel syndrome (diarrhea subtype) does not exist,
treatments are not equally effective in all patients, recommendations
change, and new therapeutic options have recently become available.
Reactions to dietary components have also been implicated in irritable
bowel syndrome, but physician knowledge about optimal testing for and
treatment of food-related allergic reactions are limited.
activity will provide caregivers with information CAM interventions for
irritable bowel disorder and irritable bowel syndrome: clinical
nutrition, probiotics, integrative use of antibiotics, dietary therapy
and hormonal interventions and will provide them with information to use
in counseling patients about CAM interventions in inflammatory and
irritable bowel syndrome, as well as other gastrointestinal conditions
in which CAM therapies can be applied.
Register by the end of this week (Oct. 20) and receive Early Bird
rates, which are $100 off. Get more information and register at: www.acamvegas.com.